Venus Remedies Ltd. - Research Center
526953 VENUSREM Group (B) BSE data
Results
Statement
More
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Mar ' 19 |
Equity share capital
13.37 |
13.37 |
12.34 |
12.34 |
12.34 |
Share application money
Preference share capital
Reserves & surplus
464.68 |
436.05 |
374.09 |
319.91 |
328.61 |
Secured loans
38.68 |
38.68 |
47.52 |
153.68 |
225.00 |
Unsecured loans
Total
516.73 |
488.09 |
447.70 |
485.94 |
565.95 |
Gross block
412.92 |
431.38 |
443.68 |
460.48 |
516.47 |
Less : revaluation reserve
Less : accumulated depreciation
213.25 |
206.71 |
199.48 |
189.01 |
169.58 |
Net block
199.68 |
224.67 |
244.20 |
271.47 |
346.89 |
Capital work-in-progress
26.10 |
25.23 |
25.11 |
24.63 |
64.76 |
Investments
20.27 |
0.14 |
0.14 |
0.14 |
0.14 |
Current assets, loans & advances
362.84 |
328.62 |
277.36 |
341.97 |
320.36 |
Less : current liabilities & provisions
92.16 |
90.57 |
99.11 |
152.28 |
166.20 |
Total net current assets
270.68 |
238.05 |
178.25 |
189.70 |
154.16 |
Miscellaneous expenses not written
Total
516.73 |
488.09 |
447.70 |
485.94 |
565.95 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
32.91 |
10.83 |
1.29 |
0.21 |
2.53 |
Number of equity sharesoutstanding (Lacs)
133.67 |
133.67 |
123.42 |
123.42 |
123.42 |